Rate the sessions (1 - 5) and offer feedback via your responses.

Question Title

* 1. Prospective Surveillance in Breast Cancer: Evidence in Action (Binkley)

Question Title

* 2. Comments, Questions?

Question Title

* 3. Updates from the OR: Lymphedema Prevention and Surgical Management of the Axilla (Murphy)

Question Title

* 4. Comments, Questions?

Question Title

* 5. ICG Fluorescence Lymphography: What We’ve Learned and Have Yet to Discover (Sevick)

Question Title

* 6. Comments, Questions?

Question Title

* 7. How effective is our MLD? (Armstrong & Ralph)

Question Title

* 8. Comments, Questions?

Question Title

* 9. Lymphedema Treatment and Optimal Care Solutions (Tactile Medical)

Question Title

* 10. Comments, Questions?

Question Title

* 11. Better Together:  Creating Strong Relationships with Physicians to Enhance Patient Care (Jordi & Gardner)

Question Title

* 12. Comments, Questions?

Question Title

* 13. Workshop 1:  Treatment Strategies for Head and Neck Lymphedema (Armstrong & Walsh)

Question Title

* 14. Comments, Questions?

Question Title

* 15. Workshop 2:  Treatment for Patients with Genital Lymphedema and/or Pelvic Floor Dysfunction (DiCecco & Hill)

Question Title

* 16. Comments, Questions?

Question Title

* 17. Workshop 3: Motivational Interviewing (Donahue & Larkin)

Question Title

* 18. Comments, Questions?

Question Title

* 19. Workshop 4:  Treatment of Radiation Fibrotic Changes, Upper Quadrant Dysfunction and Axillary Web Syndrome (Winicour & Roherty)

Question Title

* 20. Comments, Questions?

Question Title

* 21. Evaluation and Treatment considerations for the Pediatric Lymphedema Patient (Branas)

Question Title

* 22. Comments, Questions?

Question Title

* 23. Differential Diagnosis: The Importance of LAB Values in the Treatment of Patients with Multifactorial Edema/Lymphedema (Roherty)

Question Title

* 24. Comments, Questions?

Question Title

* 25. Treatment Flow and Protocols for Patients with Multifactorial Lymphedema (Oberlin)

Question Title

* 26. Comments, Questions?

Question Title

* 27. Obesity-induced Lymphedema (Thomas)

Question Title

* 28. Comments, Questions?

Question Title

* 29. Obesity and Phlebolymphedema:  What's the Connection (Dean)

Question Title

* 30. Comments, Questions?

Question Title

* 31. Lymphedema and Wounds (Trock)

Question Title

* 32. Comments, Questions?

Question Title

* 33. Panel Discussion:  Best Practice for Lymphedema

Question Title

* 34. Comments, Questions?

Question Title

* 35. Were the Course Objectives met?

Question Title

* 36. If you answered Most or Some, please explain what you thought was missing.

Question Title

* 37. Was evidence provided to substantiate material presented?

Question Title

* 38. If you answered No, please explain

Question Title

* 39. Were personal experience and observation the primary source of information?

Question Title

* 40. If you answered Yes, please explain

Question Title

* 41. Was a commercial product promoted?

Question Title

* 42. If yes, did you feel that the product promotion was the sole purpose of the course?

Question Title

* 43. Content of course was relevant to my educational needs.

Question Title

* 44. Discussion time was adequate and enhanced understanding of the subject.

Question Title

* 45. I will apply acquired knowledge to my business.

Question Title

* 46. Overall, how would you rate the 2023 POWER Lymphatics Course?

Question Title

* 47. What topics do you think would be beneficial at a future symposium?

Question Title

* 48. Please list what you enjoyed most about POWER.

Question Title

* 49. Contact Email (Optional)

T